EMERYVILLE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback